Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Phio Pharmaceuticals Corp (PHIO)

2.12   -0.04 (-1.85%) 10-23 23:24
Open: 2.23 Pre. Close: 2.16
High: 2.23 Low: 2.1
Volume: 78,488 Market Cap: 12M
Phio Pharmaceuticals Corp, formerly RXi Pharmaceuticals Corporation, is a biotechnology company. The Company is focused on developing immuno-oncology therapeutics based on its self-delivering ribonucleic acid interface (RNAi) (sd-rxRNA) therapeutic platform. The Company’s focuses on developing sd-rxRNA therapeutic compounds to be used in the context of adoptive cell transfer by targeting checkpoints or other gene targets, or to be used in immunotherapy following intratumoral injection. The Company’s pipeline include RXI-762 and RXI-804. Its sd-rxRNA compounds are designed to down-regulate the expression of a specific gene that may be over-expressed in a disease condition. The Company is developing RXI-762 for the treatment of Melanoma, Ovarian cancer and other indications. RXI-804 is an sd-rxRNA compound that is designed to suppress the expression of immune checkpoint protein, TIGIT.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.234 - 2.247 2.247 - 2.261
Low: 2.066 - 2.079 2.079 - 2.094
Close: 2.094 - 2.118 2.118 - 2.144

Technical analysis

as of: 2020-10-23 4:47:51 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 2.69     One year: 2.93
Support: Support1: 1.97    Support2: 1.64
Resistance: Resistance1: 2.30    Resistance2: 2.51
Pivot: 2.17
Moving Average: MA(5): 2.14     MA(20): 2.17
MA(100): 2.35     MA(250): 4.42
MACD: MACD(12,26): -0.02     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 40.03     %D(3): 32.11
RSI: RSI(14): 45.71
52-week: High: 18.15  Low: 1.60  Change(%): -83.9
Average Vol(K): 3-Month: 38499  10-Days: 28102

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
PHIO has closed above bottom band by 21.1%. Bollinger Bands are 68.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to PHIO's normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 23 Oct 2020
RNA-interference (RNAi) Market Size, Share, Application and players Analysis | ISIS Pharmaceuticals, Quark Pharmaceuticals Inc., RXI Pharmaceuticals - PRnews Leader

Thu, 22 Oct 2020
Is Phio Pharmaceuticals Corp. (NASDAQ:PHIO) Expensive At $2.21? Here’s How To Know. - Marketing Sentinel

Thu, 22 Oct 2020
Phio Pharmaceuticals Corp. [PHIO] Stock trading around $2.21 per share: What’s Next? - The DBT News

Tue, 20 Oct 2020
Highlights from the Ratings and Financial Report for Phio Pharmaceuticals Corp. (PHIO) - The News Heater

Mon, 28 Sep 2020
Serial biopharma founder seeks to transform an Alzheimer's drug into an autism therapy - Boston Business Journal

Fri, 18 Sep 2020
Phio Pharmaceuticals Corp. [PHIO] is -73.74% lower this YTD. Is it still time to buy? - The DBT News

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 6
Shares Float (M) 5
% Held by Insiders 6.76
% Held by Institutions 30.47
Shares Short (K) 16
Shares Short P. Month (K) 126

Stock Financials

EPS -4.508
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 3.070
Profit Margin
Operating Margin
Return on Assets (ttm) -34.1
Return on Equity (ttm) -64.0
Qtrly Rev. Growth
Gross Profit (p.s.) -0.740
Sales Per Share
EBITDA (p.s.) -1.512
Qtrly Earnings Growth
Operating Cash Flow (M) -9
Levered Free Cash Flow (M) -6

Stock Valuations

PE Ratio -0.47
PEG Ratio
Price to Book value 0.69
Price to Sales
Price to Cash Flow -1.40

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.